Outcomes in Microsurgical Management of Large Vestibular Schwannomas: A 10-Year Michigan Ear Institute Experience
Recommended Citation
Jung HD, Caskey JD, Turnbull J, Agabigum B, Bojrab DI, Babu SC. Outcomes in Microsurgical Management of Large Vestibular Schwannomas: A 10-Year Michigan Ear Institute Experience. J Neurol Surg B Skull Base 2026; 87.
Document Type
Conference Proceeding
Publication Date
2-27-2026
Publication Title
J Neurol Surg B Skull Base
Keywords
acoustic neuroma, adult, cohort analysis, conference abstract, controlled study, cranial neuropathy, facial nerve, female, human, liquorrhea, major clinical study, male, meningitis, Michigan, microsurgery, middle aged, nerve function, postoperative complication, propensity score, radiotherapy, retrospective study, stereotactic radiosurgery, surgery, tertiary care center, tumor volume, vestibular disorder, wound complication
Abstract
Objective: To compare long-term outcomes in microsurgical management of large vestibular schwannomas (≥2.5cm) with staged versus single-staged resection with or without adjuvant stereotactic radiosurgery/radiotherapy (SRS/SRT). Study Design: Retrospective case series. Setting: Tertiary referral center. Study Population: The charts of 627 patients with vestibular schwannomas managed with microsurgical resection between 2015 and 2024 at Michigan Ear Institute were reviewed. We identified and included 171 cases that had large tumors (≥2.5cm) managed with microsurgery. Intervention(s): Staged or single-stage transtemporal microsurgery with or without adjuvant SRS/SRT. Main Outcome Measure(s): Primary outcome is postoperative change in facial nerve function as measured by House-Brackmann (HB) facial nerve grading scale. Secondary outcomes include postsurgical complication rates including CSF leak, meningitis, and prolonged vestibular dysfunction. The effect of adjuvant SRS/SRT on the primary and secondary outcomes was assessed as well. Descriptive statistics were used to compare outcomes to historical controls. Propensity score matched analysis was used to analyze our cohorts controlling for age, tumor size, preoperative HB score, and receipt of SRS. Results: 117 patients underwent single stage microsurgical resection (18 with and 99 without adjuvant SRS/SRT), whereas 27 patients were managed with staged resection (7 with and 20 without adjuvant SRS/SRT). Overall, 79% of the total patient cohort had postoperative HB grade of I or II, compared with the 53% reported in the literature for management of large tumors. In both unmatched and matched cohorts, there was no statistically significant difference in postoperative facial nerve function between staged and un-staged strategies. Patients who underwent adjuvant SRS/SRT in either group had an overall higher proportion of normal postoperative facial nerve function compared with the single treatment modality group. There was no difference in rate of postoperative meningitis, wound complications and other cranial neuropathies (excluding CN VII). The single stage group had a higher rate of prolonged vestibular dysfunction. The staged group had a higher rate of CSF leak, although this rate was lower than historical controls reported in the literature. Conclusion: Large vestibular schwannomas can be treated effectively with either staged or single-staged microsurgery with or without adjuvant SRS/SRT. With judicious decision-making on the role of staged resection, use of stimulating dissectors for intraoperative facial nerve monitoring, and selective use of adjuvant SRT/SRS, large vestibular schwannomas can be managed with improved functional outcomes without compromising tumor control.(Figure Presented)(Table Presented)
Volume
87
